Cannabis Law Report

DECEMBER 8, 2021

Global Psychiatry Partnering 2014 to 2021 provides the full collection of Psychiatry disease deals signed between the world’s pharmaceutical and biotechnology companies since 2014. Access to headline, upfront, milestone and royalty data. Access Psychiatry deal headline, upfront, milestone and royalty data.

Access 52

Access Data Pharmaceutical Research and Development 52

The Cannigma

NOVEMBER 23, 2021

The app helps patients make sense of their journey by simplifying the information and supplying data-driven insights into their regimen and its effects. We delve into how data can further our understanding of different types of cannabis and why standardization is desperately needed in the industry. 0:14:10.3]

Data 52

Data Patients Access Wellness and Beauty 52

Cannabis Law Report

NOVEMBER 10, 2019

Europe Cannabis and Pain Management Devices on Cancer Pain market by key players: Cannabis Players: GW Pharmaceuticals. UNIMED PHARMACEUTICALS. Valeant Pharmaceuticals. We interviewed all major sources to collect and certify qualitative and quantitative information and to determine future prospects. Insys Therapeutics.

Pharmaceutical 45

Pharmaceutical Research and Development Data Business 45

Veriheal

FEBRUARY 21, 2023

” Restricting qualifying conditions also results in limited data collection, hindering the collective understanding of medical cannabis. Furthermore, Nugg MD’s data shows just how vital MMJ access has become in modern society’s health landscape. Many patients take MMJ for more reasons than one.

Access 98

Access Patients Chronic Pain Conditions 98

Cannabis Law Report

SEPTEMBER 8, 2021

Flora will now have the ability to quickly and efficiently reference and manage information at its cultivation and extraction facility, collect and analyze data, derive insights to find cost efficiencies, and ensure accuracy. MIAMI & TORONTO–(BUSINESS WIRE)–Flora Growth Corp. About Applied DNA Sciences Inc.

Supply Chain 95

Supply Chain Pharmaceutical Seed-To-Sale Events 95

Puff Puff Post

MARCH 10, 2020

SOURCE InMed Pharmaceuticals Inc. About InMed: InMed Pharmaceuticals is a clinical stage pharmaceutical company developing a pipeline of cannabinoid-based medications, initially focused on the therapeutic benefits of cannabinol (CBN) in diseases with high unmet medical need.

Clinical Trials 40

Clinical Trials Pharmaceutical Research and Development Cannabinoids 40

Cannabis Law Report

AUGUST 3, 2021

Many mental health disorders have treatment options, but they aren’t nearly as safe and efficacious as conventional pharmaceuticals or therapies. CSE: MXT) (OTCQB: MXTTF) aims to address these problems by pairing biometric interviews with brainwave data to create a proprietary mental health reference database. Medxtractor Corp.

Research and Development 105

Research and Development Data Conditions Therapy 105

Cannabis Law Report

JUNE 1, 2021

Given the size and scale of the study, RYAH has developed a custom software solution, using OAuth API-integration to protect the privacy of the participants in the study, with the goal of enabling a fully integrated, patient feedback and data collection capability. About RYAH Group, Inc. RYAH Group, Inc.

Clinical Trials 89

Clinical Trials Chronic Pain Data Research and Development 89

Cannabis Law Report

AUGUST 2, 2021

The nearly 3,000 participant study will capture and publish the most comprehensive data ever collected on CBD product effectiveness from 13 commercially available U.S. Radicle ACES is Institutional Review Board (IRB) approved and will capture CBD effectiveness data directly from nearly 3,000 study participants.

CBD 105

CBD Data Sleep Clinical Trials 105

Cannabis Law Report

JANUARY 21, 2022

Assay”) and Linea™ Unsupervised At-Home Sample Collection Kit (the “Linea Collection Kit”). The Linea Collection Kit is designed to enable the simple self-collection of nasal swab specimens without supervision by medical personnel. COVID-19 Assay (the “Linea 2.0 The Linea 2.0

Collective 52

Collective Therapy Research and Development Supply Chain 52

Cannabis Law Report

JUNE 23, 2021

Medicann is launching an observational study using RYAH Smart Dry Herb Inhalers in order to collect patient feedback on consumption of cannabis strains available on the Island, including strains supplied by Aurora Europe , a subsidiary of Canadian-headquartered Aurora Cannabis Inc., About RYAH Group, Inc. RYAH Group, Inc.

Programs 100

Programs Data Events Collective 100

Cannabis Law Report

JULY 27, 2021

NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids, and Biopharmaceutical Research Company (“BRC”), a specialty pharmaceutical company that holds federal licenses for importing, analyzing and manufacturing controlled substances in the U.S.,

Research and Development 98

Research and Development Pharmaceutical Sativa Extraction 98

Cannabis Law Report

JULY 19, 2021

The data from the study is expected to be embedded into the RYAH MD platform, with the goal of enabling healthcare professionals to administer THC, CBD and terpenes in milliliters, which are then expected to automatically be converted into milligrams to allow for a customized, targeted patient inhalation session. billion by 2027.

Therapy 76

Therapy Data Research and Development Events 76

Cannabis Law Report

JUNE 5, 2019

Press Release: Thailand Government Pharmaceutical Organization. The Pharmaceutical Organization, Department of Medical Affairs, signed a joint research on standard quality medical marijuana extracts for patients with chemo-allergic cancer, epilepsy, muscle contraction in patients with deteriorating nerve sheaths. Google Translation.

Pharmaceutical 40

Pharmaceutical Extraction Epilepsy Research and Development 40

Cannabis Law Report

FEBRUARY 5, 2022

Review clinical protocols to ensure the collection of data needed for regulatory submissions. 5+ years’ experience in pharmaceutical industry preferably prescription medicines, narcotics, experimental drugs or products supplied via access schemes. SKILLS/QUALIFICATIONS. Minimum tertiary qualification in relevent field.

Medicine 52

Medicine Research and Development Clinical Trials Pharmaceutical 52

Cannabis Law Report

AUGUST 1, 2022

Love it or hate it, social media can be a powerful tool for education and data collection.

Education 52

Education Access Media Data 52

Cannabis Law Report

DECEMBER 15, 2021

Review clinical protocols to ensure the collection of data needed for regulatory submissions. 5+ years’ experience in pharmaceutical industry preferably prescription medicines, narcotics, experimental drugs or products supplied via access schemes. SKILLS/QUALIFICATIONS. Minimum tertiary qualification in relevent field.

Medicine 52

Medicine Research and Development Clinical Trials Pharmaceutical 52

SpeedWeed

JULY 22, 2021

Big pharmaceutical companies and drug distributors are largely to blame for fueling the opioid epidemic in the US, killing more people than most major wars—which is why they were served one of the largest packages of class action lawsuits in history. They didn’t get here from a Mexican cartel.

Pharmaceutical 98

Pharmaceutical Packaging History Collective 98

Greenspoon Marder Cannabis Law Group Blog

JANUARY 11, 2021

It’s used by Federal statistical agencies for the collection and analysis of statistical data related to our economy. Now, the cannabis industry is relatively new, and no doubt federal statistical agencies are still figuring out how to collect data on the federally illegal, but state legal, cannabis industry.

Business 58

Business Seed-To-Sale Collective Data 58

FloridaMarijuana.net

JUNE 27, 2018

The study’s data showed that “Cannabis significantly reduced ratings of depression, anxiety, and stress.” Participants in the study recorded their personal experience when using cannabis for their depression and other mental conditions such as anxiety and stress; scientists were able to use data collected from the app to analyze the results.

Treatment 100

Treatment Marijuana Conditions Data 100

Cannabis Law Report

MARCH 22, 2020

A data firm is warning those infected with the novel coronoavirus to avoid consuming products that contain tetrahydrocannabinol (THC), the main psychoactive component of cannabis. Data CEO Julie Armstrong said her company knows the COVID-19 affects the population in a similar way to influenza. The brief survey can be taken here.

THC 59

THC Clinical Trials Data Consumption 59

Veriheal

OCTOBER 29, 2020

Is the focus on the negative impact due to the fact that role players want cannabis to remain illicit as to avoid its potential role in replacing pharmaceutical medication? The data for this graphic was provided by Jim Hudson at Hellth.com. . Scenario 2: Pharmaceuticals. However, the focus of funding remains on negative impacts.

Pharmaceutical 98

Pharmaceutical Therapy Cannabinoids Chronic Pain 98

United Patients Group

JANUARY 4, 2024

They bridge the gap between technology and healthcare, ensuring the secure and efficient collection, storage, analysis, and utilization of patient data. They work on implementing and maintaining electronic health records (EHRs), developing data-driven solutions, and training healthcare professionals on using technology effectively.

Research and Development 52

Research and Development Patients Data Policy 52

Cannabis Law Report

SEPTEMBER 1, 2021

Leading document collection and review, the incumbent is responsible for document quality and adherence to applicable regulations in collaboration with the submission and review team(s). clinical data, and preparation of CTD/DMF/QOS/SmPC where required. Role and Responsibilities.

Research and Development 105

Research and Development Supply Chain Compliance Compliance 105

The Cannigma

FEBRUARY 11, 2021

One of the things she does is collect and analyze data about cannabis products and how patients with different medical conditions respond to them. All of that data is packaged into software doctors can use to manage their patients’ medical marijuana treatment. “I I know how to collect data. That was shocking.”.

Wellness and Beauty 125

Wellness and Beauty Data Patients Medicine 125

The Joint Blog

DECEMBER 20, 2020

Separate survey data of US women previously reported that more than 20 percent of subjects with pelvic pain consume cannabis products, with 96 percent of consumers reporting symptom improvement.” Data were collected on demographics, modes of cannabis administration, symptoms treated, changes in pharmaceutical usage, and adverse events.

Sleep 49

Sleep Data Pharmaceutical Marijuana 49

Canna Law Blog

FEBRUARY 21, 2020

Last week, the Food Standard Agency (“ FSA ”), the agency responsible for protecting public health in relation to food in England, Wales and Northern Ireland (collectively, the “UK”), cleared a path for the sale of CBD-infused food for the next 12 months.

Food 95

Food CBD Legalization Hemp 95

Cannabis Law Report

NOVEMBER 23, 2021

Psilobrain is committed to our Drug Development Program, with 3 provisional patents and numerous preclinical studies in various stages of research and data collection. and is an active contributor in the pharmaceutical, nutraceutical and psychedelic wellness industries.

Supply Chain 52

Supply Chain Research and Development Pharmaceutical Compliance 52

CannaMD

JULY 23, 2020

In the novel study conducted by researchers at the University of New Mexico, nearly 2,000 people self-administered cannabis over a three-year period and reported their marijuana use via the Releaf App that was specifically designed for the study’s data collection needs.

Data 89

Data Chronic Pain Sleep Patients 89

Cannabis Law Report

SEPTEMBER 14, 2021

Comprehensive health-related outcome data from study participants, that is inclusive of highly diverse demographics and behavioral habits, further enables brands to deliver targeted formulations to specific customer segments. Step five: The OBX and Radicle Science validated product is sent to production. About Open Book Extracts.

Extraction 52

Extraction Research and Development Clinical Trials CBD 52

Puff Puff Post

NOVEMBER 5, 2019

5, 2019 /CNW/ – InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (TSX: IN; OTCQX: IMLFF), today announced the filing of a Clinical Trial Application (“CTA”) in the Netherlands to initiate a Phase 1 human clinical trial for INM-755 in healthy volunteers. VANCOUVER, Nov.

Clinical Trials 40

Clinical Trials Pharmaceutical Cannabinoids Data 40

SpeedWeed

AUGUST 11, 2021

Veterans are demanding objective cannabis drug development research, and the state of Michigan is fulfilling our collective obligation to our beloved Veteran community.”. According to data from the Veterans Association (VA), about 11-20 percent of veterans who served in Operations Iraqi Freedom and Enduring Freedom suffer from PTSD.

Clinical Trials 52

Clinical Trials Research and Development Pharmaceutical DEA 52

Cannabis Law Report

FEBRUARY 15, 2022

They offer a standardized process for making cannabis powder, highlight instruments, and demand high quality data. This small business has extraordinary ability, expertise, and intellectual property usually reserved for billion dollar pharmaceutical or public corporations.

Research and Development 52

Research and Development Trichome Digestion Edibles 52

CannaTech

APRIL 1, 2019

Eybna utilizes ethnobotany as an observational and analytical approach to medical cannabis usage data. This data is gathered, analyzed, and applied to complimentary product development. Traditional botanical knowledge and customs provide valuable practical information about potential therapeutic applications of a given plant.

Research and Development 60

Research and Development Terpenes Data Strains 60

Dykema (Cannabis Law Blog)

DECEMBER 7, 2022

The letters collectively cite violations for the introduction of CBD into food products, which appears to be a new enforcement priority for the FDA. In fact, the FDA is exceptionally concerned that high levels of CBD are harmful, stating “the available data raises serious concerns about potential harm from CBD added to conventional food.” [6].

CBD 85

CBD Food Consumption Policy 85

The Cannigma

JULY 1, 2022

Research funding is also up, and all of this data influences how we see, think and hear about the plant and its effects. Additionally, there are misleading practices of “p-hacking” where researchers can manipulate data through different statistical tests (thanks to modern computer programs) looking for statistically significant findings.

Research and Development 108

Research and Development Data THC Clinical Trials 108

Cannabis Law Report

SEPTEMBER 2, 2021

The Contract contains no minimum testing requirement; it stipulates a fixed monthly fee for sample collection site services and a separate fixed fee per individual COVID-19 test. Key end-markets include textiles, pharmaceuticals and nutraceuticals, and cannabis, among others.

Clinical Trials 99

Clinical Trials Research and Development Therapy Collective 99